News
Varian has introduced the next-generation microwave ablation solution, IntelliBlate, in Europe to treat soft tissue tumours.
Bio-Techne has announced a collaboration to distribute Spear Bio’s advanced SPEAR UltraDetect immunoassays globally.
Charlie Whelan, a Senior Director of Consulting at GlobalData, discusses the latest trends in medical devices for 2025.
Viome, with Scripps Research, is set to develop and clinically validate the first RNA test for detecting precancerous colon polyps.
Zimmer Biomet has signed a definitive agreement to acquire orthopaedic robotics company Monogram Technologies.
The US Food and Drug Administration (FDA) has cleared Caranx Medical’s TAVIPILOT Soft, an artificial intelligence (AI)-based guide software for use during Transcatheter Aortic Valve Implantation (TAVI ...
Researchers at the University of Queensland (UQ) have developed a new device to facilitate drug delivery into the brain safely.
Medical software company Tomoverse Imaging has closed its seed funding round, securing C$5m ($3.65m) for the development of tvCT.
Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...
The US FDA has granted IDE approval for Dymicron to commence a pivotal trial of its Triadyme-C cervical artificial disc ...
ClearNote Health has secured the UK Conformity Assessed (UKCA) marking for the company's Avantect Pancreatic Cancer Test.
Neuros Medical has raised $56m to support the US commercialisation of Altius direct electrical nerve stimulation system.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results